Pharma News

medical marijuana

A medical professional’s opinion on medical marijuana

Dr Charlie Easmon from Your Excellent Health Service gives a medical professional’s opinion on medical marijuana in the UK, including comment on hemp, CBD and THC.
priorities for cannabis research

The priorities for cannabis research

Here, Robin Emerson, Head of CSR at Brains Bioceutical charts the priorities for cannabis research.
UK’s clinicians

The UK’s clinicians need training in medical cannabis – here’s why

Professor Mike Barnes, Co-Founder of Maple Tree Consultancy states that the UK’s clinicians need training in medical cannabis and explains precisely why this should be.
post-covid-19 economy

Can the UK’s post-COVID-19 economy benefit from a booming medical cannabis industry?

Hannah Deacon, Co-Founder of Maple Tree Consultancy and Campaigner ponders if the UK’s post-COVID-19 economy can benefit from a booming medical cannabis industry.
EU Pharma Strategy

EU Pharma Strategy: COVID-19 shows the need for diverse supply chains 

Rex Clements, CEO at Centrient Pharmaceuticals, discusses how the upcoming EU Pharma Strategy can prevent shortages and strengthen Europe’s manufacturing base, especially for antibiotics.
OCD symptoms, CBD

Research finds cannabis could reduce OCD symptoms by 50%

OCD symptoms could be eased by atleast half in the short-term, according to a new study published in the Journal of Affective Disorders.
CBG

CBG: The mother of all Cannabinoids with broad antibacterial activity

Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains CBG (cannabigerol), a “new” cannabinoid with vast potential in cannabis research.
savage cabbage

Savage Cabbage: Where did it begin?

In early 2016, I had reached a point in life where I needed to make a life-changing decision: Read the Savage Cabbage journey on OAG.
european cannabinoid, ilesol

Ilesol Pharmaceuticals: First European cannabinoid à la carte company

Here, Ilesol Pharmaceuticals discuss how they became the first European cannabinoid company to unlock this sector of the market.
EUMCA, Brexit

EUMCA: Medical cannabis and research collaboration after Brexit

Here, we talk to Professor Trevor Jones at the European Medical Cannabis Association (EUMCA) about storing CBD, clinical trials post-Brexit and the UK-US trade deal.
narcotic

CBD: Narcotic substance or a novel food product?

CBD is at the forefront of pharmacology. So why has the European Commission changed its recommended status to “Narcotic”? Read on to find out more.
medical application of CBD, covid

COVID is shifting the conversation about the medical application of CBD

Hannah Deacon, co-founder of Maple Tree Consultancy, explores how COVID is elevating and shaping the medical application of CBD.
CBD in the UK, dose

A comprehensive guide to CBD in the UK

Here, Professor Mike Barnes discusses and answers some key questions about the world of CBD in the UK.
next big pandemic

Antimicrobial resistance: The next big pandemic?

Josep Figueras and Anna Sagan from the European Observatory on Health Systems and Policies focus here on antimicrobial resistance and ponder whether or not this could be the next big pandemic.
Quality of medicinal cannabis, purely plant

Ensuring a high and reproducible quality of medicinal cannabis

Renata Mala, PharmD, Chairman of Purely Plant GmbH, underlines the importance of ensuring high and reproducible quality when it comes to medicinal cannabis.
series B equity financing, mile high

MHL Series B equity financing and global CPG partnerships

Here, we learn how Mile High Labs, a leading processor of hemp-derived cannabinoids, have raised Series B equity financing and are preparing for global CPG partnerships.
import of medical cannabis, drug

The import of medical cannabis: Germany and the Netherlands

Kathleen Denoodt continues to enlighten us on the subject of medical cannabis, particularly imports to Germany and the Netherlands.
drug testing

Stop drug testing and start impairment testing

A new public health app by DRUID® measures factors to give an overall score of impairment, evolving the classic idea of drug testing.
New antibiotics

Finding new antibiotics: The genome way

Professor Tilmann Weber discusses how microbial genomics helps to find the next generation of antibiotics in the race against antimicrobial resistance.
what is cbd, savage cabbage

What is CBD and how does it work?

Savage Cabbage Ltd offer their expertise to explain what cannabidiol (CBD) is and how it works: Read on to find out their perspective.

Follow Open Access Government

Related Special Reports

Related eBooks